Show simple item record

dc.contributor.authorMwinzi, PN
dc.contributor.authorKaranja, DM
dc.contributor.authorKareko, I
dc.contributor.authorMagak, PW
dc.contributor.authorOrago, AS
dc.contributor.authorColley, DG
dc.contributor.authorSecor, WE
dc.date.accessioned2013-10-16T06:06:16Z
dc.date.available2013-10-16T06:06:16Z
dc.date.issued2004
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/57654
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/pubmed/15642972
dc.descriptionJournal Articleen
dc.description.abstractAbstract To investigate whether infection with human immunodeficiency virus 1 (HIV-1) affects fibrosis development in patients infected with Schistosoma mansoni, we evaluated schistosomiasis-induced pathology in the livers of Kenyan patients co-infected with HIV-1. Compared with persons with schistosomiasis alone (n = 58), there were no significant differences in distribution of ultrasound-detectable pathology in persons with HIV-1 co-infection (n = 23). Similarly, serum aspartate aminotransferase levels were not significantly different in HIV-1+ individuals. Hepatic fibrosis was associated with significantly decreased CD4+ T cell counts, even in the absence of HIV-1 infection. These data suggest that HIV-1 co-infection does not significantly alter the proportion of patients experiencing schistosomiasis-induced fibrosis, but pathology associated with S. mansoni infections leads to CD4+ T cell reductions and thereby may exacerbate the effects of HIV-1 in co-infected individualsen
dc.language.isoenen
dc.publisherUniversity of Nairobien
dc.titleShort report: Evaluation of hepatic fibrosis in persons co-infected with Schistosoma mansoni and human immunodeficiency virus 1. , ,, , , .en
dc.typeArticleen
local.publisherCollege of Health Scienceen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record